Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gocovri in Radiation Encephalopathy
NCT07125222Phase 2Not yet recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Sep 2026
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amantadine in radiation-induced encephalopathy (RIE), sponsored by Weill Cornell Medicine. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
amantadine
03
Conditions
radiation-induced encephalopathy (RIE)
Beyond the preview
Go deeper on NCT07125222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07125222.